Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
We have eagerly awaited seeing the actual results since the sponsor company (Novo Nordisk) issued a press release in August that proclaimed a 20% relative reduction of cardiovascular death, heart attack or stroke, the primary endpoint of the trial
How Do the Two Mechanisms Actually Differ
Eli Lilly is running a direct head-to-head trial comparing the two drugs (NCT06662383, 800 patients)
Product Identity Glutathione tripeptide -L-glutamyl-L-cysteinylglycine C 10 H 17 N 3 O 6 S MW 307.33 g/mol CAS 70-18-8 PubChem CID 124886
For updates on new treatments and real stories from users, see trusted health sources and stay in the loop
CBO is assuming a cheaper per-user price from Part D rebates in the first year and then Medicare negotiations starting in 2027
US$ 26.19
US$ 27.24
US$ 29.73
US$ 25.91
US$ 21.89
US$ 20.92
